Superior vena cava (SVC) syndrome comprises a constellation of clinical signs and
symptoms caused by obstruction of blood flow through the SVC. The management of …

Central vein stenosis (CVS) is commonly seen in patients receiving hemodialysis through an
arteriovenous access, threatening the usability of arteriovenous access for dialysis …

Objectives: This study sought to report periprocedural outcomes and intermediate-term
follow-up of hemodialysis patients undergoing Micra implantation. Background: Leadless …

All CVWG members are listed in Table E1 (available online at www. jvir. org). No CVWG
members received compensation or commercial support for their time and effort. Some …

Purpose: To report a retrospective observational analysis of standard balloon angioplasty
(BA) vs. paclitaxel-coated balloon angioplasty (PCBA) for symptomatic central vein …

Introduction Leadless cardiac pacemakers are an alternative modality to traditional
transvenous pacemaker systems. Recently receiving Food and Drug Administration …

Central vein stenosis is common because of the placement of venous access and cardiac
intravascular devices and compromises vascular access for dialysis. Endovascular …

Background There is no consensus regarding the optimal management of cardiovascular
implantable electronic device (CIED)–related superior vena cava (SVC) syndrome …

Central venous stenosis is a significant and frequently encountered problem in managing
hemodialysis (HD) patients. Venous hypertension, often accompanied by severe symptoms …

Background Superior vena cava (SVC) syndrome includes the clinical sequalae of facial
and bilateral upper extremity edema, dizziness, and occasional syncope. Historically, most …